BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Uniting Large Pharma\, Innovative Biotech and Leading Academic
 s to Defeat the Holy Grail Target in Precision Oncology\n\nWith tumor and
  patient heterogeneity\, the quest to target the remaining RAS mutants co
 ntinues\, and now more than ever\, we are witnessing this industry make g
 reat strides in utilizing novel modalities and elucidating mechanisms of 
 resistance. However\, treating patients with RAS mutant cancers remains n
 o easy feat\, as knowledge gaps persist in improving the depth and durabi
 lity of response\, tackling emerging resistance mechanisms and informing 
 combination strategies to improve the standard-of care for patients in ne
 ed.\n\nOwing to this\, the 6th Annual RAS-Targeted Drug Development Summi
 t returns as the central hub dedicated to every aspect of discovery and d
 evelopment of RAS\, from discovery and clinical development through to co
 mmercialization\, equipping 200+ global RAS leaders with the means to cre
 ate effective frontline RAS therapies for better patient outcomes.\n\nDat
 e and Time: Tuesday\, 24 September 2024 at 08:00 to Thursday\, 26 Septemb
 er 2024 at 16:45\n
DTEND:20240926T164500
DTSTAMP:20260512T232952Z
DTSTART:20240924T080000
LOCATION:Hilton Boston Park Plaza\, 50 Park Plaza\, Boston\, Massachusetts
 \, 02116\,
SEQUENCE:0
SUMMARY:Uniting Large Pharma\, Innovative Biotech and Leading Academics to
  Defeat the Holy Grail Target in Precision Oncology\nWith tumor and patie
 nt hetero...
UID:ffe2dad2-de61-4d39-938e-6c942ba386cc
END:VEVENT
END:VCALENDAR